-
Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and Milestone Payments for Deals Signed Since 2020 - ResearchAndMarkets.com
13 Mar 2024 13:11 GMT
…
Opthea
OptiBiotix
OptiNose
Oragenics
Oramed Pharmaceuticals
Orexigen Therapeutics
Organovo
Orgenesis
Orion
Orox …
Pan-Provincial Vaccine Enterprise
Parnell Pharmaceuticals
Par Pharmaceutical
PDL BioPharma
PDS Biotechnology
Penwest Pharmaceuticals
Pernix …
-
The Diet Pill Market is growing at a CAGR of 10.73% from 2024 to 2030 by Exacitude Consultancy
06 Mar 2024 12:54 GMT
… Orexigen Therapeutics, Pfizer Inc., TEVA Pharmaceutical … biotechnology company that discovers, develops and commercializes transformative cancer medicines … diet pills.
This … 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥
Hospital Pharmacies
Drug Stores & Retail Pharmacies …
-
US pharma giant Eli Lilly plans to introduce its blockbuster anti-diabetes drug Mounjaro to India next year
28 Feb 2024 14:48 GMT
… Lilly's weight-loss drug Zepbound, which has garnered 25 … promising market for anti-obesity drugs. We are open to collaborations … Nordisk, Vivus Pharmaceuticals, Roche Pharmaceuticals, and Orexigen Therapeutics, offer weight loss medications with diverse …
-
Limited coverage of weight-loss drugs could fuel health inequities
20 Dec 2023 22:22 GMT
… limiting coverage of pharmacologic obesity treatments.
Patients from underrepresented racial … law that established the Medicare Part D prescription drug benefit.
Meanwhile, … hydrochloride and bupropion hydrochloride (Contrave, Orexigen), “and people can get …
-
Novo’s Wegovy Has Highest Adherence Rates in New Study of Weight-Loss Drugs
06 Dec 2023 18:13 GMT
… rate of older obesity medicines.
The cohort study, … Orexigen Therapeutics’ Contrave—a combination of antidepressant buproprion and addiction treatment drug … . Last month, the FDA approved Eli Lilly’s … twice-daily weigh loss pill candidate after patients in …
-
Adherence to weight-loss drugs is far higher with Wegovy than older medicines
06 Dec 2023 08:36 GMT
… started taking Contrave from Orexigen Therapeutics and 10% of … in a pivotal clinical trial, was approved for obesity … Wegovy in clinical trials discontinued treatment due to gastrointestinal … anti-obesity medications and non-persistence with (these drugs) are …
-
Indian pharma cos speed up anti-obesity drug development amid high demand, surge in Ozempic’s sales
21 Nov 2023 18:23 GMT
… GlaxoSmithKline plc., Orexigen Therapeutics, Inc., Arena Pharmaceuticals, Inc., VIVUS, … sought-after medication.
However, according to doctors, numerous … said.
"Clinical trials show that it … drugs will have a significant impact on the treatment …
-
Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
13 Sep 2023 02:34 GMT
… 15/21
No Response
Orexigen Therapeutics, Inc.
Contrave (naltrexone hydrochloride … #47;30/14)
The Medicines Company
Cleviprex (clevidipine) IV emulsion …
Egalet US, Inc. (formerly Luitpold Pharmaceuticals, Inc.)
Sprix (ketorolac tromethamine) Nasal …
-
EU Investigated Weight-Loss Drugs Ozempic Due to Reports of Suicidal Ideation
13 Jul 2023 16:10 GMT
… treatment Ozempic and weight-loss drug Saxenda … providers. The FDA notes that these … pharmaceutical industry’s development of profitable weight-loss medications.
In clinical trials … Orexigen Therapeutics’ Contrave and Vivus Inc’s Qsymia, weight-loss pills …
-
EU investigates Ozempic, weight-loss drug Saxenda after patients report suicidal thoughts
10 Jul 2023 20:08 GMT
… s diabetes drug Ozempic and weight-loss treatment Saxenda … weight-loss drugs.
In clinical trials for Ozempic … chemistry.
Diet pills Contrave by Orexigen Therapeutics and Qsymia … pharmaceutical medicine at Kings College in London and an expert on EU drug …